Don A. Bukstein, MD

Management Team: Strategic Pharmaceutical Advisors

Don A. Bukstein - Peter V. Dicpinigaitis, MD - Bradley E. Chipps, MD

Don A. Bukstein, MD


Telephone: 202.965.2288
Email: dbukstein@SRxA.com

Curriculum Vitae (pdf file)

Don A. Bukstein, MD, is a board-certified Allergist/Immunologist, Pediatric Pulmonologist, and Director of Allergy and Asthma Research at Dean Health System, Inc. in Madison, Wisconsin.  He holds hospital staff appointments at St. Marys Hospital Medical Center, Meriter Hospital, and the University of Wisconsin Hospital in Madison.  Dr. Bukstein is also an Assistant Clinical Professor in the Department of Pediatrics and Family Practice at the University of Wisconsin-Madison.  He worked as a pediatric intensive care physician for 17 years at St. Marys Hospital Medical Center.  He is also a fellow of:  American Academy of Allergy, Asthma & Immunology; American College of Allergy, Asthma & Immunology; and American Thoracic Society. 

Dr. Bukstein received his B.A. in English Literature from Tulane University in New Orleans, Louisiana, and his medical degree cum laude from the University of Missouri-Columbia.  He completed his internship and residency in Pediatrics at Children’s Medical Center of Dallas, University of Texas Southwestern Medical School.  He also completed fellowships in Allergy/Immunology at National Jewish Hospital, and in Pediatric Pulmonary Medicine at the University of Colorado. 

Dr. Bukstein is considered a national expert in the use of clinical outcomes in managed care.  He has had numerous articles published in such peer-reviewed journals as The American Journal of Managed Care, Allergy, Pediatrics, and Journal of Clinical Outcomes Management.  He also gives approximately 50 presentations a year internationally regarding allergic disease, asthma, and quality of life/health outcomes.

Dr. Bukstein has experience as a principal investigator in more than 50 clinical research trials focusing on allergic disease, apnea, asthma, outcomes research, and sinusitis sponsored by such pharmaceutical companies as:  GlaxoSmithKline; Merck & Co., Inc.; Aventis Pharmaceuticals; AstraZeneca Pharmaceuticals; Genentech; Novartis; Forest Labs; Pfizer; and Respironics HealthScan.  He has conducted research sponsored by grants from the National Institute of Health (NIH) and NIAID.  He has also been the recipient of clinical medical school grants from Merck & Co., Inc.   

Dr. Bukstein has served as a consultant, participated in physician education programs, served on asthma advisory boards and has been a member of speaker bureaus under sponsorship of:  American Lung Association; American Thoracic Society; American College of Chest Physicians; American Academy of Allergy, Asthma & Immunology; American College of Allergy, Asthma & Immunology; AstraZeneca Pharmaceuticals; GlaxoSmithKline; Merck & Co., Inc.; Genentech; Novartis; Schering-Plough; and Aventis Pharmaceuticals.